- SII has been scaling up manufacturing by enhancing the manufacturing capability of Covishield to greater than 20 crore doses monthly.
Centre has positioned a purchase order order for 66 crore doses of Covishield vaccine from the Serum Institute of India (SII), sources informed information company PTI on Thursday. The doses can have to be supplied by December of this year, the report stated.
SII has been scaling up manufacturing by enhancing the manufacturing capability of Covishield to greater than 20 crore doses monthly. Hyderabad-based Bharat Biotech, however, has not been in a position to begin on the manufacturing of the 28.50 crore doses of Covaxin, the order for which was put in July by the Union authorities, reported PTI.
The announcement comes days after Prakash Kumar Singh, director, authorities and regulatory affairs at Pune-based SII, wrote to NITI Aayog Member (well being) Dr V Ok Paul and Union well being secretary Rajesh Bhushan, stating that the producer has supplied 60 crore of the 65 crore doses administered within the nation thus far.
“We at Serum Institute of India (SII), under the able leadership of our CEO, Adar C Poonawalla, feel proud to be part of this world’s largest COVID-19 vaccination drive and pleased to share that till date the SII alone has supplied more than 60 crore doses of Covishield to Government of India, state governments and private hospitals,” Singh said in his written communication in late August.
“This has solely been attainable as a result of of visionary management of our prime minister, steady steerage supplied by your sort self from time to time, beneficial assist of Team GoI and farsighted imaginative and prescient of our CEO,” he added.
SII has additionally supplied 12 crore doses of Covishield within the month of August, the company stated.